AU2003210181A1 - Depot medicament, carrier materials for depot medicaments, and method for the production thereof - Google Patents

Depot medicament, carrier materials for depot medicaments, and method for the production thereof

Info

Publication number
AU2003210181A1
AU2003210181A1 AU2003210181A AU2003210181A AU2003210181A1 AU 2003210181 A1 AU2003210181 A1 AU 2003210181A1 AU 2003210181 A AU2003210181 A AU 2003210181A AU 2003210181 A AU2003210181 A AU 2003210181A AU 2003210181 A1 AU2003210181 A1 AU 2003210181A1
Authority
AU
Australia
Prior art keywords
depot
carrier
carrier materials
medicament
medicaments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003210181A
Inventor
Berthold Kohler
Gabriele Reich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gelita AG
Original Assignee
Stoess & Co Gelatine
Deutsche Gelatine Fabriken Stoess and Co GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stoess & Co Gelatine, Deutsche Gelatine Fabriken Stoess and Co GmbH filed Critical Stoess & Co Gelatine
Publication of AU2003210181A1 publication Critical patent/AU2003210181A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/593—Polyesters, e.g. PLGA or polylactide-co-glycolide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G81/00—Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Biological Treatment Of Waste Water (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Detergent Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Disclosed are a depot medicament containing a pharmacological agent and a carrier, particularly a depot medicament to be administered parenterally, carrier materials for depot medicaments, and a method for producing said carrier materials. A set amount of an agent is released over time while the agent is preserved in its pharmacologically effective form. The carrier is produced by using a carrier material comprising a carrier polymer formed by a polypeptide and a biodegradable polyester which is covalently linked thereto.
AU2003210181A 2002-02-16 2003-01-24 Depot medicament, carrier materials for depot medicaments, and method for the production thereof Abandoned AU2003210181A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10206517.9 2002-02-16
DE10206517A DE10206517A1 (en) 2002-02-16 2002-02-16 Depot medicinal products, carrier materials for depot medicinal products and processes for their production
PCT/EP2003/000725 WO2003068192A1 (en) 2002-02-16 2003-01-24 Depot medicament, carrier materials for depot medicaments, and method for the production thereof

Publications (1)

Publication Number Publication Date
AU2003210181A1 true AU2003210181A1 (en) 2003-09-04

Family

ID=27674694

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003210181A Abandoned AU2003210181A1 (en) 2002-02-16 2003-01-24 Depot medicament, carrier materials for depot medicaments, and method for the production thereof

Country Status (17)

Country Link
EP (1) EP1474110B1 (en)
AT (1) ATE369123T1 (en)
AU (1) AU2003210181A1 (en)
BR (1) BR0307675A (en)
DE (2) DE10206517A1 (en)
DK (1) DK1474110T3 (en)
EA (1) EA006988B1 (en)
ES (1) ES2289304T3 (en)
HU (1) HUP0500119A3 (en)
IL (2) IL162868A0 (en)
MX (1) MXPA04006982A (en)
NO (1) NO20043860L (en)
NZ (1) NZ533103A (en)
PL (1) PL371785A1 (en)
PT (1) PT1474110E (en)
WO (1) WO2003068192A1 (en)
ZA (1) ZA200403979B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20060682A1 (en) * 2006-12-19 2008-06-20 Sicit Chemitech S P A NEW BIODEGRADABLE POLYMER DERIVATIVES
DE102007011606A1 (en) 2007-03-02 2008-09-04 Carl Freudenberg Kg Fiber-tangled structure useful as cell settling material, wound covering, medical implant and carriers for pharmaceutical active substance and for producing depot medicament, comprises fibers made of partially interlaced gelatin material

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2046830C (en) * 1990-07-19 1999-12-14 Patrick P. Deluca Drug delivery system involving inter-action between protein or polypeptide and hydrophobic biodegradable polymer
GB9211268D0 (en) * 1992-05-28 1992-07-15 Ici Plc Salts of basic peptides with carboxyterminated polyesters
PT814778E (en) * 1995-03-10 2001-11-30 Roche Diagnostics Gmbh METHODS OF PHARMACEUTICAL ADMINISTRATION CONTAINING POLYPREPEPTIDES IN THE FORM OF MICROPARTICLES AND PROCESS FOR THEIR PREPARATION
DE19813174A1 (en) * 1998-03-25 1999-05-27 Schering Ag Gas-filled microparticles, used for administering biologically active substances
JP2002542349A (en) * 1999-04-16 2002-12-10 ダブリューエム・マーシュ・ライス・ユニバーシティー Biodegradable poly (propylene fumarate) network cross-linked with poly (propylene fumarate) -diacrylate macromer

Also Published As

Publication number Publication date
DE10206517A1 (en) 2003-09-04
HUP0500119A3 (en) 2008-04-28
EP1474110A1 (en) 2004-11-10
ZA200403979B (en) 2004-11-29
EA200401012A1 (en) 2005-04-28
PL371785A1 (en) 2005-06-27
EA006988B1 (en) 2006-06-30
PT1474110E (en) 2007-10-01
WO2003068192A1 (en) 2003-08-21
IL162868A (en) 2008-03-20
BR0307675A (en) 2005-01-11
EP1474110B1 (en) 2007-08-08
DE50307874D1 (en) 2007-09-20
ES2289304T3 (en) 2008-02-01
DK1474110T3 (en) 2007-12-10
NO20043860L (en) 2004-09-15
HUP0500119A2 (en) 2005-07-28
NZ533103A (en) 2007-04-27
MXPA04006982A (en) 2004-11-10
IL162868A0 (en) 2005-11-20
ATE369123T1 (en) 2007-08-15

Similar Documents

Publication Publication Date Title
AU2586201A (en) Recycling of articles comprising hydroxy-phenoxyether polymers
CA2106451A1 (en) Isocyanate-Based Elastomer and Process for Production Thereof
ATE290351T1 (en) BIOACTIVE DEGRADABLE COMPOSITE FOR ßTISSUE ENGINEERINGß
EP2497785A3 (en) Hyaluronic acid derivative and drug containing the same
ZA200801639B (en) Cleansing compositions containing film
MXPA04006545A (en) Novel pharmaceutical dosage forms and method for producing same.
HK1004120A1 (en) Biodegradable and/or compostable polymers made from conjugated dienes such as isoprene and 2,3-dimethyl-1,3-butadiene
TW200519178A (en) Double-sided pressure-sensitive adhesive tape or sheet and process of producing the same
UA87700C2 (en) Packaged glass sealant and process for the producing thereof
TW200700458A (en) Transparent compositions, methods for the preparation thereof, and articles derived therefrom
DE602005003343D1 (en) MEDICINAL PRODUCTS WITH HIDDEN TASTE IN BREAKING MULTIPARTICLES
MXPA05012750A (en) Composition for forming an elastomeric article.
AU2002229539A1 (en) Novel polyesters, method for producing the same and depot medicaments produced from these polyesters
EP1469886B8 (en) Lyophilized pharmaceutical composition of propofol
DE50206912D1 (en) METHOD FOR CONTINUOUS PRODUCTION AND COATING OF SBC-BASED SELF-CONTAINING MATERIALS WITH AT LEAST ONE PHARMACEUTICAL AGENT
DE602005009734D1 (en) IAL AND THERMOPLASTIC OR ELASTOMER MATERIAL AND METHOD FOR PRODUCING THE ARTICLE
AU2003210181A1 (en) Depot medicament, carrier materials for depot medicaments, and method for the production thereof
BG105570A (en) Pharmaceutical compositions for modified release insulin sensitiser
AU2067802A (en) Polycarbonate composite material which can be thermoplastically shaped, methods for the production thereof, use of the same and a flame-proof polycarbonate moulded part
AU5658496A (en) Composite with sodium starch glycolate as a support material and products thereof
KR100639106B1 (en) Degradable resin composition and method for producing thereof
SG153663A1 (en) Process for the production of biodegradable, functionalised polymer particles and use thereof as pharmaceutical supports
WO2005009711A3 (en) Implant with improved homogeneity for plastic surgery and method fo the production thereof
WO2003009783A1 (en) Laminates for treating cornea and process for producing the same
WO2000067937A3 (en) Thermoplastic composite material

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase